At close: August 23 at 5:35 PM GMT+2
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Alexandre Loiseau Ph.D. | Co-Founder, CEO & Chairman | 172.64k | -- | -- |
| Mr. Come de La Tour du Pin | Chief Financial Officer | -- | -- | -- |
| Ms. Nathalie Lecoq | Chief Operating Officer | -- | -- | -- |
| Mr. Frederic Banegas Ph.D. | Chief Technology Officer | -- | -- | -- |
| Mr. François Lacombe Ph.D. | Chief Scientific Officer | -- | -- | -- |
| Mr. Daryl Donatelli | Vice President of Global Marketing & U.S. Sales | -- | -- | -- |
Mauna Kea Technologies SA
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 68
Description
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
Corporate Governance
Mauna Kea Technologies SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
October 30, 2024 at 7:30 AM UTC
Mauna Kea Technologies SA Earnings Date
Recent Events
Recent Events Information Not Available